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OBJECTIVES We sought to establish the outlook for fetuses diagnosed with atrioventricular septal defect
(AVSD) prenatally and its relation to additional cardiac, extracardiac and chromosomal
abnormalities.
BACKGROUND Prediction of likely outcome of AVSD presenting prenatally is complicated by the wide
variation in associated features.
METHODS Computerized records from 14,726 pregnancies referred to a fetal cardiology center were
reviewed retrospectively. Pathological reports, postnatal records, follow-up inquiries and
review of echocardiographic video recordings supplemented analysis of the records for all
those with AVSD.
RESULTS Atrioventricular septal defect was confirmed in 301 fetuses. Eighty-six (39%) of the 218 with
known karyotype had trisomy 21, and 21/218 (10%) had other chromosome abnormalities.
Right isomerism occurred in 37/301 (12%) fetuses, left isomerism in 62 (20%), mirror image
atrial arrangement in 2 (1%), and 200 (67%) had usual arrangement. Atrioventricular septal
defect occurred without any other intracardiac abnormality in 155 fetuses (51%). Extracardiac
abnormalities and nonkaryotypic syndromes were evident in 40 fetuses (13%, confidence
interval [CI] 9.5–17.1%). Uncomplicated cardiac anatomy was significantly associated with
the presence of karyotype abnormality (p , 0.0001). Parents opted for termination of
pregnancy in 175/298 (58.5%). For the continuing pregnancies, Kaplan-Meier estimates for
live birth, survival past the neonatal period and survival to three years were 82% (CI
75.3–88.9%), 55% (CI 46.0%–64.3%) and 38% (CI 27.1–48.6%), respectively. Fetal hydrops
and earlier year of diagnosis were independent variables with adverse influence on survival.
CONCLUSIONS Despite some improvements in the outlook for AVSD diagnosed prenatally, the overall
prognosis remains considerably poorer than that implied from surgical series. The detection
of associated cardiac and extracardiac abnormalities is important in order to give the best
indication of the likely outcome when counseling parents. (J Am Coll Cardiol 2000;36:
593–601) © 2000 by the American College of Cardiology
Atrioventricular septal defect (AVSD) is characterized by a
common atrioventricular junction and central septal defi-
ciency. Appropriate counseling of parents after prenatal
diagnosis of AVSD requires a realistic estimate of the
prognosis for the individual fetus. It is well recognized that
the spectrum of congenital heart disease diagnosed prena-
tally is different from that presenting postnatally. More
severe cases of a condition, both in terms of the cardiac
lesion itself and of associated extracardiac abnormalities, are
over-represented in fetal series, and prognosis derived from
postnatal surgical series is not generally applicable to those
diagnosed prenatally. This is especially the case with AVSD
because it is a particularly heterogeneous condition. We
report data from a large series of fetuses with AVSD seen at
our institution. We describe the outcome of the group as a
whole and also intracardiac and extracardiac features that
may affect the prognosis for an individual fetus.
METHODS
Details of pregnancies referred to the fetal cardiology
department at Guy’s Hospital have been collated in a
computerized database. Included in the database are details
of the mother and the pregnancy, the reason for specialist
fetal cardiac referral, diagnosis at initial and any further
ultrasound scans and the outcome of the pregnancy, includ-
ing karyotypic and autopsy or postnatal diagnosis. All
pregnancies in which a definitive diagnosis of AVSD was
made, either prenatally or subsequently, were identified for
further study. Additional information was sought from
autopsy reports and postnatal records, telephone inquiries
and retrospective review of video recordings of scans.
Study population. Only pregnancies in which there was a
final diagnosis of AVSD were included in the analyses of
survival and of associated anatomical and karyotypic abnor-
malities of this lesion. The study period, based on the date
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of initial consultation, was from the beginning of January
1987 to the end of December 1997. The starting date was
chosen because pregnancies with a diagnosis of AVSD
before this study period were reported in a previous paper
from this department (1). That series is contiguous with,
and does not overlap, the current series. The study was
closed to new follow-up data on May 1, 1998, but follow-up
times for survivors were calculated up to the last follow-up
available rather than up to the closing date of the study.
Associated abnormalities. Details of the cardiac anatomy
were determined from prenatal and postnatal echocardio-
grams or other postnatal investigations, from surgical find-
ings or at autopsy. Based on a detailed anatomical diagnosis,
each heart was classified according to basic features as
follows. The atrial arrangement in the fetus was determined
from atrial appendage morphology or indirectly from the
venous anatomy, as usual atrial arrangement, left isomerism,
right isomerism or mirror image atrial arrangement. The
relative size of the ventricles was classified as approximately
equal in size, right ventricle substantially larger than the left
(dominant right) or left ventricle substantially larger than
the right (dominant left). The presence or absence of
pulmonary stenosis or atresia was determined from autopsy
or Doppler findings or was inferred from pulmonary arteries
being significantly smaller than the aorta. The arterial
connection was classified as concordant, discordant, double
outlet right ventricle or single outlet. The heart rate was
classified as normal or bradycardia.
The fetal karyotype determined prenatally, postnatally or
after termination of pregnancy was recorded whenever a
result was available or otherwise recorded as unknown.
Extracardiac abnormalities and syndromes that were de-
tected prenatally or only became apparent postnatally were
noted. Markers for chromosome abnormality without other
clinical significance, such as choroid plexus cysts, were not
regarded as extracardiac abnormalities for the purposes of
this analysis. Recognized features of visceral heterotaxy,
such as asplenia and minor degrees of gut malrotation
occurring in the context of isomerism were also excluded for
the purposes of this analysis.
The presence of hydrops fetalis was noted. Isolated
pericardial effusion and early nuchal edema were specifically
excluded from this category.
Statistics. For comparison of subgroups within the whole
population, confidence intervals (CIs) were calculated using
the method of proportions (2). Confidence intervals, given
in brackets, are the 95% limits. Associations between
subgroups were analyzed using the chi-squared test, and
trends with time were examined using the Mann-Whitney
U test. Survival in continuing pregnancies was subject to
Kaplan-Meier analysis, with censoring of surviving individ-
uals at their last known follow-up date and with an
additional event-time to describe prenatal spontaneous
deaths. Differences in survival between separate subgroups
were compared using separate Kaplan-Meier analyses and
tested for statistical significance using the log-rank test.
Many characteristics were not independent but significantly
correlated with each other. Therefore, a multivariate anal-
ysis was also performed using Cox’s proportional hazards
model (3) with forward entry of variables in order to
establish significant independent variables affecting survival.
Statistical analyses were performed using Statview for Win-
dows version 4.53 (Abacus Concepts, Inc., Berkeley, Cali-
fornia) and Confidence Interval Analysis, Version 1.1 (Brit-
ish Medical Journal). In all statistical tests p , 0.05 was
regarded as significant.
Abbreviations and Acronyms
AVSD 5 atrioventricular septal defect
CI 5 confidence interval
DORV 5 double outlet right ventricle
VSD 5 ventricular septal defect
Figure 1. Summary of the major characteristics and outcome of the fetuses studied. Of the 13 fetuses in whom the final diagnosis of AVSD was made only
postnatally, the heart had been passed as normal on prenatal scan in one, and an alternative cardiac lesion had been diagnosed prenatally in the remainder,
most often in the context of marked ventricular dominance. AVSD 5 atrioventricular septal defect.
594 Huggon et al. JACC Vol. 36, No. 2, 2000
Outcome of Atrioventricular Septal Defect Diagnosed in Fetal Life August 2000:593–601
RESULTS
A final diagnosis of AVSD was made in 301 of the 14,726
pregnancies referred to the department during the study
period. The characteristics of these 301 are summarized in
Figure 1. They accounted for 17% (301/1727) of structurally
abnormal hearts seen. The principal indication for specialist
referral was suspicion of congenital heart disease on a
routine scan in 277 pregnancies. Thirty-seven of these also
had additional high risk factors for congenital heart disease
evident at referral. The reasons for referral in the remaining
24 pregnancies were extracardiac fetal abnormality (12),
family history alone (5), arrhythmia alone (3), fetal nuchal
edema (3) and drug exposure (1). The mean gestational age
at the time of the first or only specialist cardiac scan was
22.3 weeks (standard deviation 4.9, range 15 to 39 weeks).
Karyotype abnormalities. Karyotype results were available
for 218 fetuses. In a further three fetuses, a specific
karyotype abnormality (trisomy 18 or XO) was strongly
suspected at autopsy on morphological grounds, but post-
mortem karyotyping failed for technical reasons. A defini-
tive karyotype result was not available in 83 fetuses, either
because parents declined the test, because of technical
failure or because of failure to trace the results of tests
performed in other centers. An abnormal karyotype result
was obtained in 107 fetuses and strongly suspected in an
additional three. Thus, 107 (49.1%) of the 218 with a
known karyotype had abnormal chromosomes (CI 42.4% to
55.7%). The incidence of chromosome abnormality in the
series as a whole was at least 107/301 (35.5%, CI 30.1% to
41%), assuming that there were no abnormalities among
those with undetermined karyotype. The most common
karyotype abnormality was trisomy 21, which accounted for
86 (80.4%) of all 107 abnormal karyotypes identified.
Thirteen fetuses (12.1% of abnormal karyotypes) were
recognized as having trisomy 18, and four (3.7%) had
trisomy 13. The other abnormal karyotypes identified were
48XYY 121, 8q-, unbalanced translocations 14, 21 and
unknown fragment to 12 and a 22q11 microdeletion.
Additional cardiac abnormalities. A final diagnosis of
usual atrial arrangement was made in 200 (66%, CI 61.1%
to 71.8%) of 301 fetuses. Of the remainder, 62 had left atrial
isomerism, 37 had right atrial isomerism, and 2 had inverse
atrial arrangement. Dominance of the right ventricle was a
feature in 61 (20%, CI 15.7% to 24.8%) and dominance of
the left ventricle in 11 (4%, CI 1.8% to 6.4%). Concordant
ventriculoarterial connection occurred in 221 fetuses (73%
CI 68.4% to 78.4%), discordant arterial connection in 6
(1.9% CI 0.74% to 4.3%), single outlet in 2 (0.6% CI 0.08%
to 2.4%) and DORV in 72 (24% CI 19.1% to 28.7%) (of
which 11/72 had anteriorly positioned aorta). Thirty-nine
fetuses (13% CI 9.2% to 6.8%) had evidence of pulmonary
atresia or stenosis. There were 155 (52% CI 45.8% to
57.1%) fetuses in whom AVSD was an isolated cardiac
defect, in that is occurred with usual atrial arrangement and
normal arterial connections in the absence of ventricular
dominance or pulmonary obstruction.
Abnormalities of the arterial connection were associated
with isomerism. Double outlet right ventricle (DORV) was
present in 26/37 (70.3%) with right isomerism and 23/62
(37.1%) with left isomerism but only 23/200 (11.5%) with
usual atrial arrangement. A great artery relationship in
which the aorta was the more anteriorly positioned of the
great arteries (ventriculoarterial discordance, DORV with
subpulmonary ventricular septal defect (VSD) or single
outlet aorta from right ventricle) was particularly associated
with right isomerism. Anterior aorta occurred in 11 (30%)
of 37 with right isomerism but only 4/62 (6%) with left
isomerism and 4/200 (2%) with usual atrial arrangement.
Data on the size of the ventricular component were not
systematically recorded at the time of diagnosis and proved
difficult to ascertain retrospectively.
Extracardiac abnormalities. Significant extracardiac ab-
normalities and syndromes were identified in 40 of 301
cases (13.3%, CI 9.5% to 17.1%). The range of extracardiac
abnormalities was wide and included renal, gastrointestinal,
pulmonary, neurological and skeletal abnormalities as de-
tailed in Table 1. In 26 pregnancies, prenatal diagnosis of
the extracardiac abnormality was complete. Fourteen preg-
nancies, however, were complicated by extracardiac anom-
alies not recognized prenatally. The latter included three
pregnancies resulting in infants in whom a diagnosis of the
CHARGE association was made postnatally (4). Features
of this anomaly contributed to the early death of all three
infants. Other abnormalities only recognized after birth
included tracheoesophageal fistula, choanal atresia and anal
atresia. In nine pregnancies, significant extracardiac abnor-
malities were associated with proven karyotype abnormali-
ties, and karyotype abnormality was strongly suspected in
one further fetus in which the culture failed.
Association of karyotype and other abnormalities. There
was a statistically significant association between atrial
isomerism and normal karyotype (p , 0.0001). Of the 52
fetuses with isomerism and known karyotype, only two,
both with left isomerism, had karyotype abnormalities
(3.8% CI 0.5% to 13.2%). This compares with 105 karyo-
type abnormalities among 165 fetuses with usual atrial
arrangement and known karyotype (63.6% CI 56.3% to
71.0%). The karyotype abnormalities in left isomerism were
a 22q11 microdeletion and translocation of an unidentified
fragment to chromosome 12. Fetuses with an isolated defect
had a higher incidence of karyotype abnormality (77/123,
62.5%) than those with more complex anatomy (30/95,
31.6%), and this difference was statistically significant (p ,
0.0001) (95% CI for difference between proportions 18.4%
to 43.7%). The latter relationship was only partly accounted
for by the mutual association of isomerism, complex cardiac
anatomy and low incidence of karyotypic abnormality, as
there remained a significant difference (p 5 0.039), even if
only those with usual atrial arrangement were considered.
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Outcome. Outcome could not be traced in three pregnan-
cies. Parents opted to continue with 123/298 (41% CI
35.7% to 46.9%) pregnancies and for termination in 175
(59% CI 53.1% to 64.3%). Of those continuing, 104/123
(85% CI 78.2% to 90.9%) pregnancies resulted in a live-
born child, and 58 of these children (47% CI 38.3% to 56%)
were alive at latest follow-up. The duration of postnatal
follow-up was limited in many instances, and, therefore,
Kaplan-Meier analysis was performed to give unbiased
estimates of survival (Fig. 2). The duration of follow-up and
survival was from the time of birth, but an additional
event-time was added before birth to include stillbirths and
intrauterine deaths. For those with the intention to continue
with the pregnancy, the probability of live birth was 82%
(CI 75.3% to 88.9%), and 55% (CI 46.0% to 64.3%)
survived the neonatal period. By three years of follow-up,
only 38% (CI 27.1% to 48.6%) were alive. Furthermore,
based on small numbers with longer follow-up, there
appears to be continuing significant hazard beyond this age.
Factors affecting outcome. A major influence on overall
outcome is the proportion of parents opting for termination
of the pregnancy. There was no statistically significant
difference in the frequency of termination in the presence of
uncomplicated cardiac anatomy (56%) compared with those
with more complex anatomy 62% (95% CI for the difference
between proportions 117.1 to 25.2%). In those with
known karyotype, there was no significant difference in the
frequency of termination between those with normal chro-
mosomes (56%) and those with a chromosome abnormality
(60%) (95% CI for the difference between proportions
217.2 to 19.1%). The termination rate was marginally
higher in those without extracardiac anomalies (55.5%) than
Table 1. Extracardiac Defects and Syndromes Associated With AVSD
Prenatal
Extracardiac
Diagnosis Extracardiac Anomaly Karyotype Outcome
Y “Features of T18,” increased liquor, two-vessel cord unknown NND
Y Body stalk defect normal TOP
Y Cerebral ventricuolmegaly unknown TOP
Y Cleft lip normal TOP
Y Cleft lip unknown ChD
Y Facial cleft, polydactyly unknown TOP
Y Conjoined twins unknown NND
Y Cystic hygroma trisomy 21 TOP
Y Cystic left kidney 22q11 del. TOP
Y Dandy Walker malformation, micrognathia, small abnormal limbs, duplex kidney trisomy 13 UK
Y Diaphragmatic hernia normal NND
Y Duodenal atresia trisomy 21 A
Y Duodenal atresia normal TOP
Y Intestinal obstruction trisomy 21 TOP
Y Exomphalos unknown TOP
Y Exomphalos, unilateral talipes, micrognathia trisomy 18 TOP
Y Horseshoe kidney trisomy 18 IUD
Y Hypoplastic right lung unknown TOP
Y Kyphoscoliosis normal TOP
Y Lung hypoplasia and flexion deformities normal TOP
Y Microphthalmia normal TOP
Y Polycystic kidneys normal NND
Y Polydactyly normal NND
Y Absent radii unknown TOP
Y Rib and vertebral anomalies normal TOP
Y Small stomach micrognathia normal TOP
N Anal atresia, renal ectopia normal TOP
N CHARGE normal InfD
N CHARGE normal NND
N CHARGE normal InfD
N Tracheo-oesophageal fistula and choanal atresia normal NND
N Tracheo-oesophageal fistula normal NND
N Choanal atresia normal NND
N Hirschprung’s disease trisomy 21 A
N Hypospadias normal TOP
N Imperforate anus associated with sacral anomaly unknown TOP
N Polydactyly, cleft palate, microphthalmia trisomy 13 NND
N Polydactyly, talipes, hypoplastic kidneys, ambiguous genitalia normal TOP
N Russell Silver syndrome normal A
N Sturge-Weber syndrome, duodenal stenosis trisomy 21 A
ChD 5 childhood death beyond one year of age; InfD 5 infant death (1st year of life); NND 5 neonatal death (30 days); TOP 5 elective termination of pregnancy; UK 5
unknown outcome.
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those with (53.8%) (95% CI for the difference between
proportions 211.1 to 222.4%). None of these relationships
between the indicators of severity and parents’ decisions to
continue reached statistical significance. However, those
with the particular combination of left isomerism and
bradycardia did have a significantly higher termination rate
(82%, 23/28) than the rest. The proportion opting to
terminate the pregnancy had decreased to 54.8% in the
latter part of the study period (1993 onwards) compared
with 63.1% in the earlier part. A significant decrease in the
proportion opting for termination with increasing year of
diagnosis was demonstrated (Mann-Whitney U test, p 5
0.031).
Figures 3, A to D show grouped Kaplan-Meier survival
analyses for variables with a possible influence on survival,
each considered in isolation, for all pregnancies with inten-
tion to continue. In each case, the log-rank test was used to
test for statistical significance between datasets. Figure 3A
shows survival curves with and without fetal hydrops, which
are significantly different (p , 0.0001). Bradycardia, due to
sinus node dysfunction or complete heart block, which often
occurs together with fetal hydrops in fetuses with AVSD,
Figure 2. Survival for all AVSD with intention to continue. Kaplan-Meier survival curve for the 123 fetuses with AVSD where the intention was to
continue the pregnancy. An additional event time was introduced to include all spontaneous deaths occurring between diagnosis and the time of live-birth.
The broken lines indicate the 95% confidence intervals. AVSD 5 atrioventricular septal defects.
Figure 3. Pairs of survival curves for continuing pregnancies with and without various characteristics that might influence survival. (A) Hydrops fetalis; (B)
extracardiac abnormalities; (C) ventricular dominance—ventricular dominance is defined as marked inequality of the size of the ventricles as subjectively
judged by the operator at the time of the scan or at autopsy or surgery; (D) pulmonary stenosis or atresia.
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was associated with similarly poor outcome (p , 0.012,
chart not shown). Worse survival was associated with
extracardiac abnormalities than without (Fig. 3B), but the
difference was not statistically significant (p 5 0.055).
Survival for fetuses with isomerism is similar to that of
fetuses with usual atrial arrangement (p 5 0.56, chart not
shown). Survival curves with and without equal-sized ven-
tricles and pulmonary atresia or stenosis are shown in Figure
3, C and D. Disparity of ventricular size was associated with
worse survival than equal sized ventricles (p 5 0.23). There
appeared to be a trend towards improved survival in fetuses
with pulmonary atresia or stenosis in the early months of
life, compared with those with a normal pulmonary outflow.
However, there was no significant difference overall (p 5
0.13). No clear difference in survival was evident for those
with and without anteriorly positioned aorta (p 5 0.95,
chart not shown). Survival for those with and without
chromosome abnormalities was very similar (not shown).
There was, however, a nonsignificant trend for survival to be
worse with unknown karyotype (p 5 0.086). The reason for
this association is that early death is predictive of failure to
determine the karyotype rather than vice versa.
Some variables influencing survival, for example brady-
cardia and fetal hydrops, were closely related to each other,
and, therefore, further analysis was performed to identify
significant independent variables. Using Cox’s proportional
hazards model with forward entry of variables to relate
associated features to survival probability, the only statisti-
cally significant independent predictors of outcome were the
presence of fetal hydrops at presentation and the year of
presentation as shown in Table 2. The year of presentation
might be expected to influence survival because of improve-
ment in surgical results for comparable cases but also
because of improved fetal diagnosis in referring centers
increasing the proportion of surgically more favorable cases
identified prenatally. The incidence of proven chromosomal
abnormalities decreased in the last two years of the study
from 61% in 1995 to 37% in 1997, but there has been
considerable variation in the frequency of chromosomal
abnormalities within individual years, and this change may
be coincidental.
Figure 4 shows the results of a Kaplan-Meier survival
analysis for fetuses with AVSD where there was intention to
continue and where the cardiac abnormality was isolated
and uncomplicated. Excluded from this analysis are fetuses
with known karyotype abnormality, isomerism, extracardiac
abnormality, unequal ventricles or abnormal arterial connec-
tions. Only 43 of the 123 continuing pregnancies fulfilled
these criteria as having an isolated and uncomplicated
AVSD. Even this selected group had a poor outcome with
three-year survival of 55% (CI 36.7% to 74.1%).
Specific data on the occurrence and timing of surgical
procedures was available for 88 of the 104 live-born infants.
Nineteen of 43 deaths occurred within 30 days of a cardiac
operation while 21 died without any cardiac surgery being
performed, and there were three “late” deaths after surgery.
Figure 4. Survival for isolated and uncomplicated AVSD. Kaplan-Meier survival analysis for 43 fetuses with AVSD where there was intention to continue
and where the cardiac abnormality was isolated and uncomplicated. The broken lines indicate the 95% confidence intervals. AVSD 5 atrioventricular septal
defect.










e2.215 5 9.161 0.638 2.557 to 32.81 0.0005
Year of
presentation
e20.101 5 0.904 0.043 0.829 to 0.983 0.0184
Candidate variables were: year of presentation, presence of hydrops, isomerism, extracardiac abnormality, chromosomal abnormality, bradycardia, dominant right ventricle,
dominant left ventricle, pulmonary stenosis or atresia, anteriorly placed aorta and double outlet ventricle.
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Of the 18 survivors with anatomy considered unsuitable for
biventricular repair, three have completed Fontan circula-
tions, and seven have completed hemi-Fontan or Glenn
shunts. Two surgical deaths were associated with a Fontan
repair and none with a Glenn shunt. Of 27 survivors
considered suitable for eventual biventricular repair, seven-
teen have already been corrected and 10, mainly with partial
defects, remained unoperated at latest follow-up. Death
after complete repair occurred more often when coarctation
repair was required in addition, but this difference was not
statistically significant (5/8 with coarctation vs 7/21 with-
out, 95% CI for difference between proportions 20.1 to
10.68).
DISCUSSION
Atrioventricular septal defect is an important congenital
cardiac abnormality, which can be diagnosed prenatally with
considerable accuracy. Fetuses with this diagnosis do not
constitute a homogeneous group but differ in their associa-
tions with additional congenital cardiac defects, visceral
heterotaxy and chromosomal disorders. Despite routine
“four-chamber view” screening as part of the routine ultra-
sound examination, many cases of AVSD remain undetec-
ted until after birth. Those cases diagnosed prenatally are
likely to be biased, in favor of features that more readily
bring them to the ultrasonographer’s attention. Bradycardia,
fetal hydrops, marked ventricular dominance or the heart
being on the opposite side of the body to the stomach may
be recognized in circumstances where more subtle indica-
tions of AVSD might be overlooked.
The diagnosis of AVSD in the fetus should prompt not
only a detailed examination of the rest of the heart but also
of the fetus as a whole. The incidence of karyotypic
abnormalities is as high as 62% in those with the least
complicated cardiac anatomy. However, even in fetuses such
as those with isomerism, where the incidence of chromo-
somal abnormality is much less, such abnormalities are
sufficiently common that fetal karyotyping still needs to be
carefully considered. It is of particular concern that, even
when the fetal karyotype and detailed ultrasound anomaly
scans are apparently normal, significant anomalies and
genetic syndromes may become evident after birth, and
parents must be counseled with this in mind.
Early reports of fetal diagnosis of congenital heart disease
in general and of AVSD specifically have emphasised that
the outlook for the fetus diagnosed in utero is considerably
worse than would be expected from postnatal surgical series
(5). This study confirms this observation but also indicates
that there has been some improvement in prognosis both
during the period of the study and compared with a similar
earlier study from the same center. In the study of Machado
et al. (1), which included all fetuses diagnosed with AVSD
in this center before the period of this study, only 4 of the
29 fetuses studied were still alive at the time of publication.
Two of those four surviving at the time of publication are
since known to have died (6.8% crude survival). In the
current series 57 (19%) of the 301 fetuses studied were alive
at latest follow-up, though the duration of follow-up is
shorter.
The poor prognosis of congenital heart disease diagnosed
in utero is often attributed to the fact that more severe
examples are likely to be detected in the fetus. However,
even when the survival analysis was restricted to uncompli-
cated cases, the outlook in our fetal series remained consid-
erably worse than reported surgical series for AVSD repair
(6–8). Spontaneous intrauterine death is an additional
hazard after prenatal diagnosis of AVSD. Most outcome
studies report on the results from a surgical perspective and
consider only those who had surgery or at least those
considered for surgery. Furthermore, surgical series tend to
consider a particular type of surgical treatment such as
complete repair and, therefore, exclude those who were not
suitable for biventricular repair and require alternative treat-
ment strategies. A fetal series will include patients who
never reach the cardiac surgeons’ attention, either because
death occurred before surgery could be offered or unsuit-
ability for surgery as a result of poor cardiac anatomy or
severe extracardiac abnormalities.
Even in the time period of this series, there have been
significant changes in many aspects affecting the outcome.
Improvements in screening for fetal heart disease have led to
the detection of increasing numbers of cases including less
severe or less complex cases. Improvements in the surgical
technique and the intensive care are likely to have contrib-
uted significantly to the improvement in outcome. In
addition newer surgical approaches, such as the Norwood
operation, can now be offered to the parents of infants with
right ventricular dominance, which may be unsuitable for
biventricular repair.
First trimester screening using nuchal translucency mea-
surements has facilitated early diagnosis of major chromo-
some abnormality and has also been shown to be an effective
means of screening for heart defects in the absence of
chromosomal abnormality (9–11). This technique came
into widespread use towards the end of the study period and
may account for a reduction in the proportion of AVSD
with chromosomal abnormality in the last two years. In the
future, it may significantly alter the spectrum of AVSD
presenting to the fetal cardiologist by increasing prenatal
diagnosis of heart defects but decreasing the number of
undiagnosed karyotype abnormalities after the first trimes-
ter.
In predicting the likely outcome for any individual fetus
with AVSD, careful consideration should be given to
specific characteristics of the cardiac and noncardiac find-
ings. Because of the heterogeneity of AVSD, prediction of
outcome based solely on the group as a whole is not
necessarily the most appropriate for a particular individual.
Because the numbers within subcategories of AVSD are
relatively small, statistical evidence for differences in out-
come related to anatomical and other features is difficult to
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establish. However, until further data are available, it seems
reasonable to base counseling on those differences that do
seem to be apparent from the current data. Hydrops fetalis
at presentation was significantly associated with poor out-
come. Isomerism did not appear to have any independent
influence on outcome. Extracardiac abnormality had a
negative, but not significant, effect on survival. Some of
these abnormalities had not been diagnosed prenatally and
could not be considered at the time of the initial counsel-
ling, but the nature as well as the presence of the extracar-
diac abnormality is likely to be important in determining
prognosis. The detection rate of such abnormalities might
also improve with better experience of fetal medicine units.
Unequal-sized ventricles as a risk factor for survival is
consistent with the findings of a postnatal study considering
complete repair of complicated AVSD in the presence of
usual atrial arrangement only (12). Some infants with
unequal sized ventricles, deemed unsuitable for biventricular
repair, will continue to be exposed to the long-term hazard
associated with the establishment and maintenance of a
Fontan-type circulation.
After postnatal presentation, the size of the ventricular
component of the defect is considered to be a major
determinant of outcome. Where the ventricular component
is restrictive or absent, surgical repair may be safely deferred
beyond the first months of life, and the outcome is better
than that for defects with a large ventricular component
(13). In our study, information about the size and presence
of a ventricular component of the defect was not docu-
mented in many cases. Of those fetuses known to have a
small or absent ventricular component, half had complex
cardiac anatomy, which may have prompted recognition of
a cardiac problem, and it is likely that most uncomplicated
“partial” AVSDs are still unrecognized in fetal life. How-
ever, if screening continues to improve, it is likely to lead to
increased recognition of these. It is important to recognize
that fetuses in whom such a defect can be distinguished in
utero may well have a significantly better outcome than that
of AVSD diagnosed in fetal life generally. The observation
that the size of the ventricular component may get smaller
as the pregnancy advances indicates that prognostications
based on the size of the ventricular component of the defect
at presentation may sometimes prove unreliable (14).
Study limitations. Short duration of follow-up will bias
the crude survival figures towards better survival. In the
Kaplan-Meier analysis, observations on those alive at the
latest follow-up are censored at that time interval and so
provide information about the likelihood of survival up to
that duration but do not bias the survival estimate beyond
the time for which they were under observation. Compar-
ison of survival curves for different subgroups has limita-
tions, which are of particular importance when the duration
of follow-up is limited. In this study, the number of children
known to be alive beyond four years of follow-up is limited
to seven. This is because, despite the relatively large number
of affected pregnancies studied, the numbers for study are
rapidly reduced because of terminations and early deaths for
other reasons. Also, follow-up after diagnosis made close to
the closing date is necessarily short, and follow-up data
beyond the neonatal period is lacking for some children
followed up at other centers. The survival curves for differ-
ent subgroups differ in the slope and shape, and this
necessitates some caution in the interpretation of the results.
For example, in fetuses with evidence of pulmonary atresia
or stenosis, the early mortality appears less than that of those
without these features. However, in some of these infants
definitive, high-risk surgery may have been deferred in favor
of simpler shunt operations or conservative management,
and the incidence of later deaths, associated with definitive
surgery, within this subgroup may prove to be considerable
with more extensive follow-up.
The prospect for survival of a fetus diagnosed with AVSD
is one of several factors, which may be taken into account by
parents in deciding whether or not to continue the preg-
nancy. In this study, we were unable to demonstrate
statistically significant relationships between indicators of
severity of the condition in a particular fetus and decisions
of the parents to terminate the pregnancy or continue,
except for left isomerism with bradycardia. Incomplete
information on these indicators may have been available at
the time that a decision was reached. However, it is our
impression that parents’ personal beliefs and attitudes are
usually a stronger influence on decision making than the
details of the abnormality itself. Also, the quality of life of
the survivors is an issue that is of major concern but for
which detailed data are still not available.
Conclusions. Despite some improvements in the outlook
for AVSD diagnosed prenatally, the overall prognosis re-
mains considerably worse than that implied from surgical
series. The detection of associated cardiac and extracardiac
abnormalities is important in order to give the best indica-
tion of the likely outcome when counselling parents.
Reprint requests and correspondence: Dr. I. Huggon, Fetal
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